Basit öğe kaydını göster

dc.contributor.authorOzen, Seza
dc.contributor.authorAlikasifoglu, M
dc.contributor.authorBakkaloglu, A
dc.contributor.authorDuzova, A
dc.contributor.authorJarosova, K
dc.contributor.authorNemcova, D
dc.contributor.authorBesbas, N
dc.contributor.authorVencovsky, J
dc.contributor.authorTuncbilek, E
dc.date.accessioned2019-12-10T10:51:58Z
dc.date.available2019-12-10T10:51:58Z
dc.date.issued2002
dc.identifier.issn1462-0324
dc.identifier.urihttps://doi.org/10.1093/rheumatology/41.2.223
dc.identifier.urihttp://hdl.handle.net/11655/14499
dc.description.abstractObjectives. To study G-->A -238 and G-->A -308 polymorphisms in the promoter region of the tumour necrosis factor (TNF) alpha gene in patients with juvenile idiopathic arthritis (JIA). We analysed whether there were any associations between these polymorphisms and the type of JIA and/or the clinical course of the disease in two populations. Methods. The first group consisted of 51 Turkish JIA patients and the second consisted of 159 JIA patients from the Czech Republic. Healthy individuals (93 and 100) from each country served as controls. Subgroups of JIA were defined according to the Durban criteria. The course of the disease was defined on the basis of the physician's global evaluation of disease activity, the swollen and tender joint count and the erythrocyte sedimentation rate. Results. In both JIA cohorts, the distribution of genotypes was not significantly different among the types of JIA. The G-->A -238 polymorphism did not have an effect on the patients' outcome in either group. The G-->A -308 polymorphism was significantly associated with a poor outcome in the Turkish group (P=0.005) but there was no association in the Czech patients. Some features of JIA in Turkish patients differed from those in Czech patients. Conclusions. Genetic differences may accompany the phenotypic differences found in the Turkish group. Although larger numbers of patients are clearly needed to verify this, we suggest that the G-->A -308 polymorphism may be operative in defining disease outcome in selected groups.
dc.language.isoen
dc.publisherOxford Univ Press
dc.relation.isversionof10.1093/rheumatology/41.2.223
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectRheumatology
dc.titleTumour Necrosis Factor Alpha G -> A-238 And G -> A-308 Polymorphisms In Juvenile Idiopathic Arthritis
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalRheumatology
dc.contributor.departmentÇocuk Sağlığı ve Hastalıkları
dc.identifier.volume41
dc.identifier.issue2
dc.identifier.startpage223
dc.identifier.endpage227
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster